These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 398916)

  • 21. Rifampicin (RFP) trial in lepromatous leprosy.
    Koticha KK; Pade SS; Chulawala RG; Juwatkar PS
    Lepr India; 1982 Jul; 54(3):441-7. PubMed ID: 6757577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pyrazinamide as a part of combination therapy for BL and LL patients--a preliminary report.
    Katoch K; Sreevatsa ; Ramanathan U; Ramu G
    Int J Lepr Other Mycobact Dis; 1988 Mar; 56(1):1-9. PubMed ID: 2453596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of single-dose ROM therapy plus low-dose convit vaccine as an adjuvant for treatment of paucibacillary leprosy patients with a single skin lesion.
    Majumder V; Saha B; Hajra SK; Biswas SK; Saha K
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):283-90. PubMed ID: 11221091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Immuno-allergic accidents with rifamipcin].
    Flageul B; Wagner L; Cottenot F
    Acta Leprol; 2001-2002; 12(2):71-8. PubMed ID: 12136739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Follow up of BL/LL patients on a slightly modified WHO regimen of multidrug therapy.
    Katoch K; Ramu G; Ramanathan U; Sengupta U; Sreevatsa
    Indian J Lepr; 1987; 59(1):36-43. PubMed ID: 3611859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemotherapeutic trials with different regimens containing rifampicin in paucibacillary type of leprosy cases--a preliminary report.
    Katoch K; Ramu G; Ramanathan U
    Indian J Lepr; 1985; 57(3):499-506. PubMed ID: 3831087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of a new fixed duration (12 weeks) multi-drug regimen of bactericidal drugs in multibacillary leprosy.
    Tejasvi T; Khaitan BK; Khanna N; Pandhi RK; Singh MK
    Indian J Lepr; 2006; 78(4):329-37. PubMed ID: 17402345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of paucibacillary leprosy with a regimen containing rifampicin, dapsone and prothionamide.
    Katoch K; Natarajan M; Bhatia AS; Yadav VS
    Indian J Lepr; 1992; 64(3):303-12. PubMed ID: 1431319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Short-term clinical and histological evaluation of combination drug therapy of leprosy in Mayotte].
    Cnudde F; Julvez J; Rivière JP
    Acta Leprol; 1987; 5(2):115-24. PubMed ID: 3303804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Field trial on efficacy of supervised monthly dose of 600 mg rifampin, 400 mg ofloxacin and 100 mg minocycline for the treatment of leprosy; first results.
    Mane I; Cartel JL; Grosset JH
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):224-9. PubMed ID: 9251595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of rifampicin, clofazimine and dapsone in treating 296 cases of multibacillary leprosy].
    Li WZ
    Zhonghua Yi Xue Za Zhi; 1987 Jan; 67(1):1-3. PubMed ID: 3109697
    [No Abstract]   [Full Text] [Related]  

  • 32. [Present evaluation of hansenian treatment by association of chemotherapy and immunostimulation (author's transl)].
    Saint-Andre P; Louvet M; Giraudeau P; Discamps G; Schlecht B
    Med Trop (Mars); 1978; 38(3):331-49. PubMed ID: 723581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relapses in leprosy patients treated with rifampicin plus dapsone after varying periods of dapsone monotherapy.
    Li HY; Ran SP; Weng XM; Li TG; Deng XH; Li FT
    Indian J Lepr; 2001; 73(1):1-10. PubMed ID: 11326592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short-term multidrug therapy in multibacillary leprosy--review of 80 cases in two provinces of China (1983-1988).
    Li HY; Yu XL; Zhang MS; Duan CX; Huang WB; Zhang SB; Zhu K; Ma JF
    Int J Lepr Other Mycobact Dis; 1989 Sep; 57(3):622-7. PubMed ID: 2778368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA damage studies in untreated and treated leprosy patients.
    Gandhi G; Singh B
    Mutagenesis; 2004 Nov; 19(6):483-8. PubMed ID: 15548761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A clinico-pathological study of multidrug regimen in paucibacillary leprosy.
    Kar PK; Jha PK; Panayach JS; Snehi PS
    Indian J Lepr; 1988 Apr; 60(2):235-41. PubMed ID: 3192972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fixed duration MDT in paucibacillary leprosy.
    Mathai R; George S; Jacob M
    Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):237-41. PubMed ID: 2071980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A preliminary clinical trial of rifampicin in leprosy.
    Bhide MB; Desai AC; Ganapati R
    Lepr India; 1976 Oct; 48(4 Suppl):781-3. PubMed ID: 1026816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [2 cases of recurrence resistant to rifampicin in lepromatous leprosy].
    Cottenot F; Wallach D; Flageul B; Pennec J; Wastiaux K
    Ann Dermatol Venereol; 1983; 110(9):703-4. PubMed ID: 6660769
    [No Abstract]   [Full Text] [Related]  

  • 40. Intermittent rifampicin therapy in lepromatous leprosy.
    Girdhar BK; Sreevatsa ; Desikan KV
    Lepr India; 1980 Jan; 52(1):89-96. PubMed ID: 6991816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.